Place · Level 3
Vitamin D
从阳光抵达皮肤 · 到肝脏改名 · 到肾脏点火 · 最后服务全身
Story path
Chapter 1
Sun → Skin
Sun → Skin
The plain version first: sunlight builds vitamin D because the UVB in it strikes your skin and remodels a cholesterol 'cousin' molecule there into the raw material for D. It's also why winter, overcast days, or staying indoors leave your body making less of its own D. Here's what actually happens at the molecular level.
The basal layer of skin holds a molecule called 7-dehydrocholesterol (7-DHC) — originally an intermediate on the cholesterol synthesis pathway that the body conveniently repurposes as the precursor for vitamin D. When UVB photons (280–315 nm) strike the B-ring of 7-DHC, a photochemical reaction breaks the C9-C10 σ bond, opens the ring, and yields previtamin D3.
This step needs no enzyme — pure photon energy. But there are three hidden prerequisites:
Wavelength must be right — UVA (315–400 nm) doesn't work, visible light doesn't work, glass blocks UVBSkin pigment intercepts — melanin in darker skin absorbs UVB, cutting synthesis efficiency by ~50%Angle must be sufficient — above 35°N in winter, the low sun angle means UVB is almost entirely absorbed by the atmosphere, which is why 'winter depression + northern populations low on D' is a geographic fact
Minutes later, previtamin D3 spontaneously isomerizes at skin temperature into D3 (cholecalciferol) — the starting point for the body's own D production.
The basal layer of skin holds a molecule called 7-dehydrocholesterol (7-DHC) — originally an intermediate on the cholesterol synthesis pathway that the body conveniently repurposes as the precursor for vitamin D. When UVB photons (280–315 nm) strike the B-ring of 7-DHC, a photochemical reaction breaks the C9-C10 σ bond, opens the ring, and yields previtamin D3.
This step needs no enzyme — pure photon energy. But there are three hidden prerequisites:
Wavelength must be right — UVA (315–400 nm) doesn't work, visible light doesn't work, glass blocks UVBSkin pigment intercepts — melanin in darker skin absorbs UVB, cutting synthesis efficiency by ~50%Angle must be sufficient — above 35°N in winter, the low sun angle means UVB is almost entirely absorbed by the atmosphere, which is why 'winter depression + northern populations low on D' is a geographic fact
Minutes later, previtamin D3 spontaneously isomerizes at skin temperature into D3 (cholecalciferol) — the starting point for the body's own D production.
Clinical: how much sun
'How much sun per day is enough' has no single answer — actual synthesis depends on four variables:Skin pigment (Fitzpatrick I–VI): at the same UV intensity, type I–II (Northern European pale) needs 10–15 min; type V–VI (deep brown / black) needs 30–60 minSurface area exposed: face + arms + lower legs cover ~25% of body surface, the common baseline; full body is 4–6× more efficient than face + handsSolar altitude angle: UVB is most effective when sun elevation > 50°; above 35°N in winter midday, actual UVB is near zeroSeason / latitude / altitude / air pollution
By Holick's rough estimate: 10–15 min of spring/summer midday sun on 25% of pale skin yields 1000–3000 IU of D3; in winter in northern cities, it approaches zero.
A few practical points:
10–20 min of normal outdoor activity around midday in spring/summer is enough — no need for scorching direct sunIn winter, on rainy days, or when housebound, food + a D3 supplement of 1000–2000 IU/day is usually neededDark-skinned residents at high latitudes basically fall short year-round — supplementation is the norm
SPF 30+ sunscreen blocks 95–98% of UVB, and long-term strict sun protection meaningfully reduces D synthesis. This is not a reason to skip sunscreen (the skin-cancer cost far exceeds D deficiency), but it explains why modern lifestyles make D supplementation matter more than for the previous generation.
Chapter 2
Food → Gut
Food → Gut
The other route comes from food — smaller, but steady:
D3 (cholecalciferol): animal sources — fatty fish (wild salmon ~600 IU / 100 g), egg yolk, cod liver oil, fortified milkD2 (ergocalciferol): fungal source — UV-irradiated mushrooms (UVB converts ergosterol into D2)
Both are fat-soluble, and absorption requires a fat carrier: they form mixed micelles with dietary fat in the small intestine, are taken up by enterocytes, packaged into chylomicrons, and travel via the lymphatic system (not the portal vein). This explains two things: D supplements on an empty stomach absorb poorly, while adding a spoon of olive oil or a meal with fat can double absorption; and people post-cholecystectomy, with steatorrhea, or with Crohn's disease have high rates of D deficiency.
For potency in the body, D3 raises serum 25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. about 1.5–2× more than D2, which is why supplements typically use D3 rather than D2.
D3 (cholecalciferol): animal sources — fatty fish (wild salmon ~600 IU / 100 g), egg yolk, cod liver oil, fortified milkD2 (ergocalciferol): fungal source — UV-irradiated mushrooms (UVB converts ergosterol into D2)
Both are fat-soluble, and absorption requires a fat carrier: they form mixed micelles with dietary fat in the small intestine, are taken up by enterocytes, packaged into chylomicrons, and travel via the lymphatic system (not the portal vein). This explains two things: D supplements on an empty stomach absorb poorly, while adding a spoon of olive oil or a meal with fat can double absorption; and people post-cholecystectomy, with steatorrhea, or with Crohn's disease have high rates of D deficiency.
For potency in the body, D3 raises serum 25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. about 1.5–2× more than D2, which is why supplements typically use D3 rather than D2.
Clinical: doses & frequency
D supplement dosing should be individualized to baseline and target.Stratified by 25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. baseline (nmol/L):
< 30 (deficient): typically a loading dose, 50,000 IU/week × 8 weeks, then switch to maintenance30–50 (insufficient): 2000–4000 IU/day, recheck at 12 weeks50–75 (generally sufficient): 1000–2000 IU/day maintenance> 75 (ideal): maintain current intake
For frequency, daily dosing keeps the steadiest serum level and is usually preferred. Once-weekly 7000 IU equals daily 1000 IU on average, and most studies show equivalence. Once-monthly 50,000 IU was found in some elderly studies (Sanders 2010 JAMA) to actually increase falls — the large transient peak may disturb calcium signaling, so it's generally discouraged. The historical 'annual 500,000 IU injection' has been abandoned due to elevated fall and fracture risk.
Synergies with other nutrients:
With magnesium: both D hydroxylation steps need Mg as cofactor — supplementing D without enough Mg works poorlyWith K2: D increases calcium absorption, K2 decides whether calcium goes to bone or to vessels — the 'D + K2' combo is reasonable in elderly + high-cardiovascular-risk populationsWith calcium: 800–1200 mg/day calcium + D is the standard combination for osteoporosis
On safety: the UL for healthy adults is 4000 IU/day; long-term doses > 10,000 IU/day carry hypercalcemia risk; the minimum toxic dose is around 50,000 IU/day sustained for months; a typical supplement contains 1000–5000 IU, so toxicity within a year is essentially impossible.
A few traps to avoid: 'all-in-one $15 D + K2 + Mg + black pepper + magic-blend' formulas usually under-dose individual components; 'liquid D absorbs better than tablets' has no evidence — tablets with a meal containing fat absorb just as well; D3 from 'lanolin extract vs lichen extract' is chemically identical, source doesn't affect bioequivalence.
Chapter 3
Liver · 25-hydroxylation
Liver · 25-hydroxylation
The plain version first: the D from skin or food is still just 'raw stock' — it goes to the liver for its first stamp, becoming the 25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. a blood test measures, the number a doctor reads to judge whether your D is adequate. Here's the detail of that step.
Once D3 enters the bloodstream it binds vitamin D-binding protein (vitamin D-binding protein: The blood transport protein that carries vitamin D to organs.) and is carried to the liver. Hepatocyte CYP2R1 (main) + CYP27A1 (backup) add a hydroxyl to D3, producing 25-hydroxyvitamin D, 25(OH)D.
A few traits of this step worth remembering: it is barely under feedback regulation, so what you take is roughly what shows up in blood; the half-life is 2–3 weeks, so one measurement reflects status over a recent stretch of time, not 'whether you got sun today'; 80–90% of the body's D pool exists as 25(OH)D — the circulating currency of vitamin D.
Once D3 enters the bloodstream it binds vitamin D-binding protein (vitamin D-binding protein: The blood transport protein that carries vitamin D to organs.) and is carried to the liver. Hepatocyte CYP2R1 (main) + CYP27A1 (backup) add a hydroxyl to D3, producing 25-hydroxyvitamin D, 25(OH)D.
A few traits of this step worth remembering: it is barely under feedback regulation, so what you take is roughly what shows up in blood; the half-life is 2–3 weeks, so one measurement reflects status over a recent stretch of time, not 'whether you got sun today'; 80–90% of the body's D pool exists as 25(OH)D — the circulating currency of vitamin D.
Clinical
'Vitamin D blood test' measures 25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. — not D3, and not the downstream active form 1,25(OH)₂D.Clinical reference ranges differ slightly between guidelines, roughly:
< 30 nmol/L (< 12 ng/mL): deficient, directly linked to rickets / osteomalacia30–50 nmol/L: insufficient50–125 nmol/L (20–50 ng/mL): sufficient, the target zone most IOM and Endocrine Society guidance agree on> 125 nmol/L: no additional health benefit; > 375 starts to carry hypercalcemia risk
So on a lab report, the 25(OH)D number is enough — no need to measure 'active D', which swings too much within a single day.
Misconceptions
'Bad liver means you can't activate D': in most liver diseases the 25-hydroxylation pathway remains intact, because the CYP2R1 + CYP27A1 dual backup is hard to lose simultaneously. The real bottleneck is renal 1α-hydroxylation.'If the test is low, hit it with 50,000 IU': D is a fat-soluble, storage-form molecule with a long half-life — 1000–4000 IU/day with a meal containing fat typically pulls a < 30 baseline up to 75 within 8–12 weeks. Instantaneous mega-doses get downregulated by the metabolic pathway.
'D2 = D3': not equal. D3 raises 25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. about 1.5–2× more than D2 and has a longer half-life. Choose D3 (cholecalciferol), not D2 (ergocalciferol).
Chapter 4
Kidney · 1α-activation
Kidney · 1α-activation
The plain version first: this is the step where vitamin D truly 'ignites' — the kidney adds the final touch that turns it into the active hormone managing calcium, bone, and a thousand genes. Read on for the molecular detail if you want it.
In renal tubule cells, CYP27B1 (1α-hydroxylase) adds another hydroxyl, producing 1,25-dihydroxyvitamin D, 1,25(OH)₂D = calcitriol — the truly active hormone.
This step is precisely regulated: parathyroid hormone: Released when blood calcium dips — it pulls calcium back into the blood from bone, kidney, and gut. (parathyroid hormone) turns it on when blood calcium is low; FGF23 (secreted by osteocytes) turns it off when blood phosphate is high; blood calcium and phosphate form direct negative feedback; magnesium is a CYP27B1 cofactor, so the step stalls when Mg is deficient.
Its half-life is only 4–15 hours (vs weeks for 25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status.) — the body doesn't want it loose in circulation. It works by binding the nuclear vitamin D receptor (vitamin D receptor: The cellular 'socket' that vitamin D plugs into to carry out its instructions.) — a transcription factor that enters the nucleus directly and regulates expression of about 3% of the human genome (roughly 1000 genes).
So D isn't just 'a vitamin' — its role is closer to a steroid hormone. That's the molecular root of 'low D leaves a little of everything low'.
In renal tubule cells, CYP27B1 (1α-hydroxylase) adds another hydroxyl, producing 1,25-dihydroxyvitamin D, 1,25(OH)₂D = calcitriol — the truly active hormone.
This step is precisely regulated: parathyroid hormone: Released when blood calcium dips — it pulls calcium back into the blood from bone, kidney, and gut. (parathyroid hormone) turns it on when blood calcium is low; FGF23 (secreted by osteocytes) turns it off when blood phosphate is high; blood calcium and phosphate form direct negative feedback; magnesium is a CYP27B1 cofactor, so the step stalls when Mg is deficient.
Its half-life is only 4–15 hours (vs weeks for 25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status.) — the body doesn't want it loose in circulation. It works by binding the nuclear vitamin D receptor (vitamin D receptor: The cellular 'socket' that vitamin D plugs into to carry out its instructions.) — a transcription factor that enters the nucleus directly and regulates expression of about 3% of the human genome (roughly 1000 genes).
So D isn't just 'a vitamin' — its role is closer to a steroid hormone. That's the molecular root of 'low D leaves a little of everything low'.
Extrarenal activation
'The kidney is the only site of activation' is an old view overturned in the past 20 years. Modern understanding is that CYP27B1 is expressed in many tissues, which convert 25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. into active 1,25(OH)₂D locally and act locally (autocrine / paracrine).Extrarenal tissues known to express CYP27B1 include:
Macrophages + dendritic cells — this is why D's effects on the immune system are strongSkin keratinocytes — the basis for topical calcipotriol (a D3 analog) treating psoriasisBreast epithelium, prostate, colon epithelium, placentaParathyroid glands (negative feedback loop)Beta cells (pancreatic islets)
A few clinical implications:
This explains why D affects so many seemingly unrelated organs — it's activated and acts on-site in many tissues, not dependent on central renal regulationIn sarcoidosis and some lymphomas, runaway macrophage CYP27B1 activation raises blood calcium (hypercalcemia) — a cause of high calcium other than 'D toxicity'Chronic kidney disease (CKD) patients have falling renal CYP27B1 → low systemic 1,25(OH)₂D → secondary hyperparathyroidism + bone disease; clinically treated with active D analogs (calcitriol, paricalcitol) rather than ordinary D3
This is the molecular root of 'D is not just a bone matter': the kidney is the central currency printing house, but every tissue has its own small printer deciding whether local D signaling is needed.
Chapter 5
Bone
Bone
The plain version first: active D's most famous job is getting calcium into the body — it's the key that opens the gut door, and without it most of the calcium you eat can't get in. Here are the three specific things it does for bone and calcium.
Active D does three things in bone and calcium metabolism:
1. Opens the gut door: vitamin D receptor: The cellular 'socket' that vitamin D plugs into to carry out its instructions. in duodenal epithelial nuclei activates the TRPV6 calcium channel + calbindin-D9k + PMCA1b calcium pump, actively moving calcium from gut lumen into blood. Without D, this active channel is closed and passive diffusion covers only about 10%.
2. Reduces renal leak: in the distal renal tubule, TRPV5 + calbindin-D28k cooperate to reabsorb calcium from urine back into blood.
3. Bidirectional bone control: at low doses promotes osteoblast mineralization of new bone; when blood calcium is severely low, it activates osteoclasts (receptor activator of NF-κB ligand: A signal molecule that tells osteoclasts to break down bone. pathway) to borrow calcium from bone — blood calcium is the priority, bone is the 'final calcium reserve'.
This explains why piling on calcium without D is essentially wasted — the gut simply doesn't open the door. Likewise, for D to actually work it usually needs to be paired with magnesium (activation), K2 (directing calcium to bone rather than vessels), and calcium (raw material) — a team, not a hero.
Active D does three things in bone and calcium metabolism:
1. Opens the gut door: vitamin D receptor: The cellular 'socket' that vitamin D plugs into to carry out its instructions. in duodenal epithelial nuclei activates the TRPV6 calcium channel + calbindin-D9k + PMCA1b calcium pump, actively moving calcium from gut lumen into blood. Without D, this active channel is closed and passive diffusion covers only about 10%.
2. Reduces renal leak: in the distal renal tubule, TRPV5 + calbindin-D28k cooperate to reabsorb calcium from urine back into blood.
3. Bidirectional bone control: at low doses promotes osteoblast mineralization of new bone; when blood calcium is severely low, it activates osteoclasts (receptor activator of NF-κB ligand: A signal molecule that tells osteoclasts to break down bone. pathway) to borrow calcium from bone — blood calcium is the priority, bone is the 'final calcium reserve'.
This explains why piling on calcium without D is essentially wasted — the gut simply doesn't open the door. Likewise, for D to actually work it usually needs to be paired with magnesium (activation), K2 (directing calcium to bone rather than vessels), and calcium (raw material) — a team, not a hero.
Rickets & osteomalacia
Severe D deficiency is not a 'subclinical concept' — it's a disease that actually happened historically and still occurs today.In children it presents as rickets: failure of bone mineralization, long bones become soft and bent; presentation includes bow legs / knock knees / pigeon chest / rachitic rosary, soft skull, delayed and decayed tooth eruption. Historically, in 19th-century industrial-revolution London, smoke plus crowded urban tenements meant children almost never saw the sun and rickets reached ~90% prevalence — this was the origin of the D story (McCollum discovered D in 1922; cod-liver-oil-fortified milk arrived in the 1930s). Modern cases still occur, mostly in dark-skinned + strictly veiled-religious-dress + northern-migrant + extended-breastfed-without-D-supplement infants, and they're not rare.
In adults it presents as osteomalacia: bone density may look normal (DEXA may be unimpressive) but the bone matrix is undermineralized, presenting as bone pain, muscle weakness, and stress fractures. 'Unexplained diffuse bone pain + proximal weakness + recurrent low-trauma fractures' with severely low 25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. (< 25 nmol/L) should prompt this diagnosis — it's easily mistaken for 'fibromyalgia / depression / aging'.
For prevention, several standard public-health practices exist:
All infants from birth: 400 IU/day D3 (whether breast or formula fed), strongly recommended by the AAP (American Academy of Pediatrics)Children / adolescents: 400–600 IU/day + diet + outdoor activityPregnancy: 600 IU/day (fortified foods + supplement)Food fortification policy (fortified milk, fortified grains) is the main public-health tool
One reminder: calcium supplements cannot substitute for D — no matter how much calcium you add, without D opening the gut channel, the calcium can't enter. D first, then calcium is the supplement-order logic.
Chapter 6
Immune
Immune
The plain version first: nearly every immune cell carries a vitamin-D 'receiver', so D really is involved in immunity — but the key point is that supplementing mainly helps when you're already short, and adds little once you have enough. Here are the mechanisms and the tiered evidence.
Almost every immune cell carries vitamin D receptor: The cellular 'socket' that vitamin D plugs into to carry out its instructions. — macrophages, T cells, B cells, dendritic cells. The mechanisms by which active D acts on the immune side are reasonably clear:
Induces antimicrobial peptides cathelicidin (LL-37) + defensins, directly killing bacteria, fungi, viruses, especially sensitive against *Mycobacterium tuberculosis* (the modern explanation for 'sanatorium sun cures for TB')Modulates T-cell differentiation, shifting Th1/Th17 (pro-inflammatory) toward Treg (regulatory, anti-inflammatory) — epidemiologically associated with autoimmune disease (MS, T1D, psoriasis) incidence and D statusSuppresses excessive inflammation, downregulating the nuclear factor kappa B: The cell's inflammation master switch (a transcription factor) — when flipped, it turns inflammation on. pathway and reducing interleukin-6: A pro-inflammatory signal molecule (cytokine) released by immune cells during inflammation. and tumor necrosis factor alpha: A strong pro-inflammatory signal molecule that runs high in chronic inflammation. release
Clinical evidence is stratified. The Martineau 2017 BMJ meta-analysis shows that for people with baseline < 25 nmol/L, supplementation reduces respiratory infections by ~70%; for people with baseline > 75, the benefit is near zero. Supplementing D works for correcting deficiency; piling on top of sufficiency has no evidence.
Almost every immune cell carries vitamin D receptor: The cellular 'socket' that vitamin D plugs into to carry out its instructions. — macrophages, T cells, B cells, dendritic cells. The mechanisms by which active D acts on the immune side are reasonably clear:
Induces antimicrobial peptides cathelicidin (LL-37) + defensins, directly killing bacteria, fungi, viruses, especially sensitive against *Mycobacterium tuberculosis* (the modern explanation for 'sanatorium sun cures for TB')Modulates T-cell differentiation, shifting Th1/Th17 (pro-inflammatory) toward Treg (regulatory, anti-inflammatory) — epidemiologically associated with autoimmune disease (MS, T1D, psoriasis) incidence and D statusSuppresses excessive inflammation, downregulating the nuclear factor kappa B: The cell's inflammation master switch (a transcription factor) — when flipped, it turns inflammation on. pathway and reducing interleukin-6: A pro-inflammatory signal molecule (cytokine) released by immune cells during inflammation. and tumor necrosis factor alpha: A strong pro-inflammatory signal molecule that runs high in chronic inflammation. release
Clinical evidence is stratified. The Martineau 2017 BMJ meta-analysis shows that for people with baseline < 25 nmol/L, supplementation reduces respiratory infections by ~70%; for people with baseline > 75, the benefit is near zero. Supplementing D works for correcting deficiency; piling on top of sufficiency has no evidence.
Beyond hype
Vitamin D has been one of the most over-promoted nutrients of the past decade, while also being one of the few with genuine immune mechanism — so it deserves a careful tiered look at the evidence.Strong evidence (RCT level):
Supplementation reduces respiratory infections in the deficient — Martineau 2017 BMJ (25 RCTs, n=11,321): baseline < 25 nmol/L cuts risk significantly (~70%), all-population reduction only ~12%Prevents childhood rickets and adult osteomalacia — causal at 100%Falls prevention (elderly, 25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. > 60 nmol/L) — reduces by 20–30%Second-line therapy for hyperparathyroidism
Moderate evidence:
Tuberculosis adjunctive therapy — D speeds sputum conversion, partially supported (Martineau 2011)Multiple sclerosis (MS) epidemiologic link with D deficiency — higher MS incidence at high latitude, sufficient D may slow progression, but RCT treatment effect is weakType 2 diabetes prevention — the D2d trial (NEJM 2019, n=2,423): 4000 IU/day in borderline subjects reduced progression by 12% (borderline significance)
Weak or null evidence:
COVID-19 treatment or prevention — multiple RCTs inconsistent, consensus is that correcting baseline deficiency helps but supplementing the general population doesn't prevent COVIDCancer prevention — VITAL trial (NEJM 2019, n=25,871, 5.3 yr): 2000 IU/day D3 vs placebo, no difference in total cancer incidence; reduced metastatic cancer in a subgroup (exploratory)Cardiovascular prevention — VITAL likewise showed no difference in major cardiovascular eventsDepression treatment — D-Vitaal RCT (Aronson 2021): 1200 IU/day did not improve elderly depression'Immunity booster' has no measurable definition — pure marketing
Bottom line: correcting deficiency (< 50 nmol/L) yields real health benefit; once you're sufficient (50–125 nmol/L) further D doesn't add benefit on most hard endpoints; super-high levels (> 125 nmol/L) provide no benefit and may cause harm (higher fall and kidney-stone risk). 'D is a miracle molecule' is marketing; 'D as deficiency-correction is a basic health investment' is reality.
Chapter 7
Muscle
Muscle
The plain version first: being short on D can leave you weak-legged and prone to falls, especially in older people — because muscle contraction also relies on the calcium D manages. But again, supplementing helps only to correct a deficiency; using it to boost athletic performance has no evidence. Here's the muscle-level detail.
Skeletal myocytes express vitamin D receptor: The cellular 'socket' that vitamin D plugs into to carry out its instructions., and D in muscle mainly does several things:
Facilitates calcium uptake into the sarcoplasmic reticulum — muscle contraction requires Ca²⁺ release from this store, so without the calcium reservoir contraction is weakActivates the mTOR complex 1: The main working form of mTOR — the switch that directly drives protein synthesis. pathway (the master switch for protein synthesis), contributing to muscle hypertrophyMaintains type-II fast-twitch fibers — the core fiber type for fall resistance and explosive power, which preferentially atrophies in D-deficient elderlyImproves neuromuscular junction transmission
Clinically, the low-D + elderly combination produces the classic triad of 'proximal weakness + unsteady gait + falls', presenting as difficulty rising from a chair or climbing stairs. Bringing 25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. above 60 nmol/L reduces fall risk by ~20–30%.
Distinguish carefully: correcting deficiency works; using mega-doses of D to boost athletic performance has no supporting evidence.
Skeletal myocytes express vitamin D receptor: The cellular 'socket' that vitamin D plugs into to carry out its instructions., and D in muscle mainly does several things:
Facilitates calcium uptake into the sarcoplasmic reticulum — muscle contraction requires Ca²⁺ release from this store, so without the calcium reservoir contraction is weakActivates the mTOR complex 1: The main working form of mTOR — the switch that directly drives protein synthesis. pathway (the master switch for protein synthesis), contributing to muscle hypertrophyMaintains type-II fast-twitch fibers — the core fiber type for fall resistance and explosive power, which preferentially atrophies in D-deficient elderlyImproves neuromuscular junction transmission
Clinically, the low-D + elderly combination produces the classic triad of 'proximal weakness + unsteady gait + falls', presenting as difficulty rising from a chair or climbing stairs. Bringing 25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. above 60 nmol/L reduces fall risk by ~20–30%.
Distinguish carefully: correcting deficiency works; using mega-doses of D to boost athletic performance has no supporting evidence.
Falls prevention
Falls in the elderly are the single leading cause of disability and death in the 65+ population. D was once considered to have some of the strongest clinical evidence here, but after 2018 large RCTs substantially revised this — it now requires separating 'real deficiency' from 'already sufficient' as two distinct scenarios.Mechanistically, D theoretically affects falls along several routes:
Type-II fast-twitch fibers (explosive power) preferentially atrophy under D deficiency, and they determine whether you can rapidly adjust when balance is suddenly lostThe cerebellum and vestibular nuclei contain vitamin D receptor: The cellular 'socket' that vitamin D plugs into to carry out its instructions., involving the balance-sensing systemMyelin maintenance of proprioceptive nerves partly depends on DCognitive function (sufficient D correlates with mild cognitive improvement), with alertness affecting fall risk
The evidence timeline matters:
Bischoff-Ferrari 2009 BMJ meta (historical positive): 800 IU/day D3 vs placebo, falls RR ≈ 0.81 (~19% reduction), with hip fractures down 18% — the core data behind ten-year-old clinical D recommendationsUSPSTF 2018 (JAMA) systematic re-review no longer recommends D solely for fall prevention in community-dwelling healthy eldersVITAL-Falls subset (LeBoff 2020): no benefit in the falls subgroup, supplementing already-sufficient elders adds nothingD-Health (Waterhouse 2023, Lancet Diab Endocrinol, n=21,315): 60,000 IU/month × 5 years, neutral on falls / fracture outcomes2024 NIH ODS current position: Vitamin D supplementation does not reduce the numbers of falls or injuries in community-dwelling adults 65+Mega-bolus is worse: Sanders 2010 JAMA single annual 500,000 IU increased falls — the transient peak may disturb neuromuscular Ca signaling
The post-2024 consensus can be summarized as: D + fall prevention is meaningful only in the correction-of-confirmed-deficiency (< 50 nmol/L) phase, not 'all elders should take D to prevent falls'; for healthy community elders who are already sufficient (> 60 nmol/L), adding D doesn't prevent falls, and the opportunity cost is not doing resistance training / balance training / medication review.
In practice:
For 65+ recommend testing 25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status., maintain target 50–75 nmol/L (the now more conservative guideline range)For documented deficiency: 800–2000 IU/day D3 + calcium 1000–1200 mg + resistance training (evidence for the latter is stronger than D)For high-fall-risk individuals (fall within the past year / gait instability / complex medications): comprehensive assessment + physical therapy + home modification + vision check + medication review — D is not the core intervention
Remember falls are multifactorial — vision, medications, muscle strength, balance, home environment, nighttime bathroom trips, hypotension, dementia all participate. In already-sufficient populations, resistance + balance training + medication review have far higher ROI than continued D supplementation.
'High-dose D for athletes boosts performance' has weak evidence: D supplementation can restore normal strength in deficient athletes; no extra effect once sufficient (Owens 2018 review).